FAQ: Nutriband Inc. Presentation at MicroCap Rodeo Conference 2025

What is the main announcement in this content?

Nutriband Inc. (NASDAQ: NTRB) announced it will participate in the MicroCap Rodeo Conference in New York City on September 25, 2025, with Chairman Serguei Melnik presenting at 10 a.m. about the company’s operational highlights and AVERSA platform technology.

When and where is the MicroCap Rodeo Conference taking place?

The conference will be held in New York City on September 25, 2025. The specific presentation by Nutriband’s Chairman will occur at 10 a.m. during the event.

Who will be presenting for Nutriband at the conference?

Company Chairman Serguei Melnik will be presenting on behalf of Nutriband Inc. He will discuss the company’s operational highlights, growth initiatives, and strategic direction for the AVERSA platform technology.

What topics will be covered in Nutriband’s presentation?

The presentation will cover operational highlights, growth initiatives, and the strategic direction for Nutriband’s AVERSA platform technology, which is an abuse-deterrent technology for transdermal pharmaceutical products.

How can interested parties access the presentation if they cannot attend in person?

The presentation will be webcast live, and registration is available for interested parties who wish to view it remotely. No specific registration link is provided in the content.

What is Nutriband’s primary business focus?

Nutriband is primarily engaged in developing a portfolio of transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch incorporating the company’s AVERSA technology to prevent abuse and misuse of drugs.

What is the AVERSA technology mentioned in the content?

AVERSA is Nutriband’s abuse-deterrent technology that can be incorporated into any transdermal patch to prevent abuse, misuse, diversion, and accidental exposure of drugs with abuse potential, particularly focusing on pharmaceutical applications.

Where can I find more information about Nutriband and updates on NTRB?

The company’s website is www.nutriband.com, and the latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB. The full press release can be viewed at https://ibn.fm/gMG2M.

Why is this conference presentation significant for investors?

This presentation provides investors with direct insights into Nutriband’s strategic direction, growth initiatives, and the development of their AVERSA technology platform, which represents the company’s core business focus in abuse-deterrent pharmaceuticals.